Boston Scientific Market Cap 2006-2018 | BSX

Historical market capitalization for Boston Scientific (BSX) over the last 10 years. The current market cap for Boston Scientific (BSX) as of March 31, 2018 is $46.53B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.003B $9.048B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $119.518B 18.50
Abbott Laboratories (ABT) United States $111.818B 23.45
Stryker (SYK) United States $64.600B 25.84
Baxter (BAX) United States $40.022B 28.64
Zimmer Biomet Holdings (ZBH) United States $22.815B 14.37
ResMed (RMD) United States $15.531B 32.48
Smith & Nephew SNATS (SNN) United Kingdom $15.356B 0.00
Perrigo (PRGO) Ireland $10.500B 14.72
Bio-Rad Laboratories (BIO) United States $9.132B 73.65
Hill-Rom Holdings (HRC) United States $6.219B 22.34
ICU Medical (ICUI) United States $6.169B 57.40
Canopy Growth (CGC) Canada $5.511B 0.00
Agios Pharmaceuticals (AGIO) United States $5.252B 0.00
Insulet (PODD) United States $5.222B 0.00
Haemonetics (HAE) United States $5.160B 53.14
Hutchison China MediTech (HCM) China $4.366B 0.00
Neogen (NEOG) United States $4.219B 67.46
GW Pharmaceuticals (GWPH) United Kingdom $4.127B 0.00
National Vision Holdings (EYE) United States $3.044B 0.00
NuVasive (NUVA) United States $2.767B 27.97
Quidel (QDEL) United States $2.615B 114.44
Abaxis,Inc (ABAX) United States $1.905B 64.07
Phibro Animal Health (PAHC) United States $1.899B 28.20
NxStage Medical (NXTM) United States $1.821B 0.00
VAREX IMAGING (VREX) United States $1.447B 22.29
Eagle Pharmaceuticals (EGRX) United States $1.244B 34.80
Cardiovascular Systems (CSII) United States $1.184B 0.00
Orthofix (OFIX) $1.110B 33.82
Owens & Minor (OMI) United States $1.080B 10.86
OraSure Technologies (OSUR) United States $1.033B 62.63
AtriCure (ATRC) United States $1.027B 0.00
Cerus (CERS) United States $0.973B 0.00
Omeros (OMER) United States $0.968B 0.00
TG Therapeutics (TGTX) United States $0.952B 0.00
MacroGenics (MGNX) United States $0.938B 0.00
Surmodics (SRDX) United States $0.799B 136.93
LeMaitre Vascular (LMAT) United States $0.713B 41.96
Meridian Bioscience (VIVO) United States $0.671B 23.66
PetIQ (PETQ) United States $0.647B 0.00
Insys Therapeutics (INSY) United States $0.612B 0.00
Lantheus Holdings (LNTH) United States $0.530B 13.85
Evolus (EOLS) United States $0.467B 0.00
Surface Oncology (SURF) United States $0.402B 0.00
Utah Medical Products (UTMD) United States $0.363B 24.05
Cytosorbents (CTSO) United States $0.360B 0.00
Quanterix (QTRX) United States $0.346B 0.00
NanoString Technologies (NSTG) United States $0.321B 0.00
BioLife Solutions (BLFS) United States $0.299B 0.00
Rockwell Medical (RMTI) United States $0.235B 0.00
Chimerix (CMRX) United States $0.220B 0.00
Bovie Medical (BVX) United States $0.171B 0.00
Fonar (FONR) United States $0.169B 10.23
Chembio Diagnostics (CEMI) United States $0.157B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.130B 0.00
Female Health (VERU) United States $0.110B 0.00
Trinity Biotech (TRIB) Ireland $0.104B 31.00
Oramed Pharmaceuticals (ORMP) Israel $0.095B 0.00
United-Guardian (UG) United States $0.088B 20.48
Neurotrope (NTRP) United States $0.081B 0.00
InfuSystems Holdings (INFU) United States $0.075B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.049B 0.00
Capricor Therapeutics (CAPR) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Akers Biosciences Inc (AKER) United States $0.035B 0.00
Myomo (MYO) United States $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00